Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are shown in bold with a green bullet. See more at Help:Related changes.
List of abbreviations (help):
- D
- Edit made at Wikidata
- r
- Edit flagged by ORES
- N
- New page
- m
- Minor edit
- b
- Bot edit
- (±123)
- Page byte size change
- Temporarily watched page
6 June 2024
- diffhist Phosphate 06:16 +92 Pbsouthwood talk contribs (Adding short description: "Anion, salt, functional group or ester derived from a phosphoric acid", overriding automatically generated description) Tag: Shortdesc helper
- diffhist m FGF7 00:45 +4 Teaktl17 talk contribs (→Function: +wl)
- diffhist m FGF7 00:43 +18 Teaktl17 talk contribs (→Function: +wl)
- diffhist m FGF7 00:40 +4 Teaktl17 talk contribs (→Function: +wl)
- diffhist m FGF7 00:35 +4 Teaktl17 talk contribs (→Function: +wl)
- diffhist m FGF7 00:35 +4 Teaktl17 talk contribs (→Function: +wl)
- diffhist m FGF7 00:33 +4 Teaktl17 talk contribs (→Function: +wl)
- diffhist m FGF7 00:32 +4 Teaktl17 talk contribs (→Function: +wl)
5 June 2024
- diffhist FGF19 20:54 −4 Jrfw51 talk contribs (Reverted 1 edit by 43.245.234.102 (talk): Unclear edit) Tags: Twinkle Undo
- diffhist m Statin 20:38 −13 Uwsi talk contribs
- diffhist m Momelotinib 17:55 +1 Mr. X 235528 talk contribs
- diffhist Rituximab 17:54 +39 Ward20 talk contribs (→Chronic fatigue syndrome: change name to agree with article nomenclature)
- diffhist FGF19 13:37 +4 43.245.234.102 talk Tag: Reverted
- diffhist m Larotrectinib 06:01 +23 MKumaru talk contribs (Added continuous flow chemistry wiki link ot the word) Tag: Visual edit
- diffhist m Larotrectinib 05:58 +773 MKumaru talk contribs (Added flow chemistry to the article) Tag: Visual edit
- diffhist m Diarrhea 05:40 −262 Sgconlaw talk contribs (Minor copyediting)
4 June 2024
- diffhist m Cancer immunotherapy 15:21 +212 M.D. Shahinyan talk contribs (→Types and categories) Tag: Visual edit
- diffhist m Insulin-like growth factor 1 10:41 0 Bergman Natalie 1982 talk contribs (typo) Tag: Visual edit
- diffhist m Insulin-like growth factor 1 10:39 +9,889 Bergman Natalie 1982 talk contribs (IGF-1 and MASLD) Tag: Visual edit
- diffhist Ranibizumab 05:12 −84 Boghog talk contribs (consistent citation formatting)
- diffhist Lorlatinib 03:34 +186 Whywhenwhohow talk contribs (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5) Tag: IABotManagementConsole [1.3]
- diffhist Lorlatinib 02:55 +265 Whywhenwhohow talk contribs (add ref)
- diffhist Lorlatinib 02:52 +2,897 Whywhenwhohow talk contribs (Rescuing 14 sources and tagging 0 as dead.) #IABot (v2.0.9.5) Tag: IABotManagementConsole [1.3]
- diffhist m Lorlatinib 02:49 +23 Whywhenwhohow talk contribs (script-assisted date audit and style fixes per MOS:NUM)
- diffhist Lorlatinib 02:49 +1,855 Whywhenwhohow talk contribs (update infobox, description, effects uses, refs, links, templates; move text; ce)
3 June 2024
- diffhist m Dostarlimab 17:14 +1 Jautism talk contribs (added a space.) Tags: Visual edit Mobile edit Mobile web edit
- diffhist m Dostarlimab 17:13 −5 Jautism talk contribs (Avelumab and durvalumab were described as PD-1 inhibitors, they are not, they are PD-L1 inhibitors. PD-1 inhibitors include pembrolizumab and Nivolumab.) Tags: Visual edit Mobile edit Mobile web edit
- diffhist Tarlatamab 16:45 −60 Marbletan talk contribs (no longer a stub)
- diffhist m Adenosine triphosphate 14:28 +46 I am Being Here to Help You talk contribs (→History: {{interlanguage link}]) Tag: Visual edit
- diffhist Lorlatinib 12:23 −25 Noxoug1 talk contribs (copy edit) Tag: Visual edit
- diffhist Lorlatinib 12:22 +371 Noxoug1 talk contribs (→Clinical studies: CROWN study) Tag: Visual edit
- diffhist Lorlatinib 12:20 +348 Noxoug1 talk contribs (→Clinical studies: CROWN study) Tag: Visual edit
- diffhist Lorlatinib 12:19 +322 Noxoug1 talk contribs (→Clinical studies: CROWN study) Tag: Visual edit
- diffhist m Receptor tyrosine kinase 07:46 +4 Kku talk contribs (link negative feedback)
- diffhist m Interleukin 2 07:40 +4 Kku talk contribs (link negative feedback)
- diffhist m Everolimus 07:38 +4 Kku talk contribs (link negative feedback)
2 June 2024
- diffhist m Lymphatic system 16:16 −29 Quarangle talk contribs (Undid revision 1226190110 by 31.218.84.22 (talk) Nonsensical short description edit) Tag: Undo
- diffhist m IGFBP3 13:09 +4 Kku talk contribs (link synovial fluid)
- diffhist m Transferase 10:10 +4 Kku talk contribs (link glycosaminoglycan)
- diffhist m Platelet-derived growth factor 10:08 +4 Kku talk contribs (link glycosaminoglycan)
- diffhist m Hepatocyte growth factor 10:05 +4 Kku talk contribs (link glycosaminoglycan)
- diffhist Lorlatinib 06:15 +1,062 Lfstevens talk contribs (better ref. in future, don't revert. if the info is accurate and if you don't like the source, find a better one.) Tag: Visual edit
- diffhist Lorlatinib 04:39 −627 Whywhenwhohow talk contribs (Undid revision 1226767019 by Lfstevens (talk) need WP:MEDRS source) Tag: Undo
- diffhist Janus kinase inhibitor 02:55 −293 Mikalra talk contribs (wiki links, syntax, removing outdated 2017 status)
1 June 2024
- diffhist Lorlatinib 18:09 +627 Lfstevens talk contribs (trial vs crizotinib) Tags: Reverted Visual edit
- diffhist Statin 05:48 +58 Davidindia talk contribs (Adding local short description: "Class of drugs to lower cholesterol", overriding Wikidata description "class of drugs used to lower cholesterol levels") Tag: Shortdesc helper
- diffhist Template:Targeted cancer therapeutic agents 03:51 +91 Whywhenwhohow talk contribs (add entries)
- diffhist Sugemalimab 03:47 +4 Whywhenwhohow talk contribs (add wl)
- diffhist N Sugemalimab 03:45 +6,655 Whywhenwhohow talk contribs (create)
- diffhist Aflibercept 03:37 −54 Boghog talk contribs (consistent citation formatting)